← Back to Screener
Talphera, Inc. Common Stock (TLPH)
Price$0.81
Favorite Metrics
Price vs S&P 500 (26W)-41.02%
Price vs S&P 500 (4W)2.04%
Market Capitalization$41.60M
All Metrics
Book Value / Share (Quarterly)$0.42
P/TBV (Annual)2.37x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-31.81
Price vs S&P 500 (YTD)-29.73%
Gross Margin (TTM)152.49%
Net Profit Margin (TTM)-0.51%
EPS (TTM)$-0.38
10-Day Avg Trading Volume0.14M
EPS Excl Extra (TTM)$-0.38
EPS (Annual)$-0.50
Dividend / Share (Annual)$23.88
ROI (Annual)-162.53%
Gross Margin (Annual)614639.02%
Net Profit Margin (5Y Avg)-888.45%
Cash / Share (Quarterly)$0.47
ROA (Last FY)-71.31%
Revenue Growth TTM (YoY)492614.23%
EBITD / Share (TTM)$33.91
ROE (5Y Avg)-248.82%
Operating Margin (TTM)-0.46%
Cash Flow / Share (Annual)$-0.74
P/B Ratio2.17x
P/B Ratio (Quarterly)2.12x
Net Income / Employee (Annual)$-1
Net Interest Coverage (TTM)61.47x
ROA (TTM)-61.75%
EV / EBITDA (TTM)0.04x
EPS Incl Extra (Annual)$-0.50
Current Ratio (Annual)3.56x
Quick Ratio (Quarterly)-1.50x
3-Month Avg Trading Volume0.28M
52-Week Price Return59.69%
Revenue / Employee (TTM)$107
Tangible BV / Share (Quarterly)$0.23
P/S Ratio (Annual)63.90x
Asset Turnover (Annual)0.03x
52-Week High$1.57
Operating Margin (5Y Avg)-1812.46%
EPS Excl Extra (Annual)$-0.50
26-Week Price Return-37.03%
Quick Ratio (Annual)-1.34x
13-Week Price Return-19.30%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)6.83x
Enterprise Value$38.601
Asset Turnover (TTM)60.54x
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)77.48x
Pretax Margin (Annual)-1580.18%
Cash / Share (Annual)$0.52
3-Month Return Std Dev77.83%
Gross Margin (5Y Avg)122870.11%
Net Income / Employee (TTM)$-1
ROE (Last FY)-162.53%
Net Interest Coverage (Annual)-12.01x
EPS Basic Excl Extra (Annual)$-0.50
Receivables Turnover (TTM)1.00x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.38
Receivables Turnover (Annual)0.00x
ROI (TTM)-125.76%
P/S Ratio (TTM)0.03x
Pretax Margin (5Y Avg)-639.11%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$0.31
Price vs S&P 500 (52W)29.86%
Year-to-Date Return-27.09%
5-Day Price Return2.34%
EPS Normalized (Annual)$-0.50
ROA (5Y Avg)-33.38%
Net Profit Margin (Annual)-2825.96%
Month-to-Date Return11.29%
EBITD / Share (Annual)$51.99
Operating Margin (Annual)-2594.32%
LT Debt / Equity (Annual)173.40x
ROI (5Y Avg)-89.47%
LT Debt / Equity (Quarterly)121.75x
EPS Basic Excl Extra (TTM)$-0.38
P/TBV (Quarterly)3.93x
P/B Ratio (Annual)1.12x
Inventory Turnover (TTM)2.78x
Pretax Margin (TTM)-0.51%
Book Value / Share (Annual)$0.47
Price vs S&P 500 (13W)-19.99%
Beta0.74x
Revenue / Share (TTM)$33.40
ROE (TTM)-125.76%
52-Week Low$0.38
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.13
4.13
4.13
4.13
Industry Peers — Pharmaceuticals(308)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
TLPHTalphera, Inc. Common Stock | 0.03x | 492614.23% | 152.49% | — | $0.81 |
LLYEli Lilly & Co. | 13.08x | 44.70% | 83.04% | 27.59% | $903.99 |
JNJJohnson & Johnson | 5.94x | 7.87% | 67.95% | 14.90% | $234.54 |
ABBVABBVIE INC. | 6.04x | 8.57% | 71.62% | -2.88% | $208.99 |
MRKMerck & Co., Inc. | 4.41x | 1.31% | 78.55% | 21.23% | $115.46 |
AZNAstraZeneca PLC | 5.28x | 8.63% | 81.31% | 21.88% | $200.47 |
NVSNovartis AG | 4.98x | 8.91% | 75.82% | 15.26% | $149.73 |
NVONovo-Nordisk A/S | 3.62x | 6.43% | 80.98% | 20.66% | $40.93 |
ABTAbbott Laboratories | 3.66x | 6.59% | 56.50% | 8.20% | $95.47 |
PFEPfizer Inc. | 2.47x | -1.64% | 75.81% | -3.51% | $27.22 |
BMYBristol-Myers Squibb Co. | 2.47x | -0.22% | 72.63% | — | $58.96 |
About
Talphera Inc. is a pharmaceutical company developing therapies for medically supervised clinical settings. Its pipeline centers on nafamostat product candidates, including Niyad and LTX-608, with a focus on pre-filled syringe formulations to optimize drug delivery.